Literature DB >> 32172822

Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome.

Sandrine Valade1, Eric Mariotte2, Elie Azoulay2.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare and severe condition that can lead patients to the intensive care unit. HLH diagnosis may be challenging, as it relies on sets of aspecific criteria. Several organ dysfunctions have been described during HLH, including hemostasis impairment found in more than half of the patients. The most frequently reported anomaly is a decrease in the fibrinogen level, which has been associated with higher mortality rates. Coagulation impairment study in patients with HLH represents an interesting field of research, as little is known about the mechanism leading to hypofibrinogenemia.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coagulation; Fibrinolysis; Hemophagocytic lymphohistiocytosis; Hemorrhage

Mesh:

Year:  2020        PMID: 32172822     DOI: 10.1016/j.ccc.2019.12.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  13 in total

Review 1.  Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?

Authors:  Violetta Opoka-Winiarska; Ewelina Grywalska; Jacek Roliński
Journal:  BMC Med       Date:  2020-07-15       Impact factor: 8.775

2.  Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation.

Authors:  Marcel Levi
Journal:  Eur J Intern Med       Date:  2020-05-16       Impact factor: 4.487

3.  COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm.

Authors:  Cirino Botta; Alessia Indrieri; Eugenio Garofalo; Flavia Biamonte; Andrea Bruni; Pino Pasqua; Francesco Cesario; Francesco Saverio Costanzo; Federico Longhini; Francesco Mendicino
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

4.  Massive intraperitoneal hemorrhage in patients with COVID-19: a case series.

Authors:  Vahid Reisi-Vanani; Zahra Lorigooini; Mohamad Ali Dayani; Mehrandokht Mardani; Fereidoun Rahmani
Journal:  J Thromb Thrombolysis       Date:  2021-04-28       Impact factor: 2.300

5.  Analysis of Prognostic Risk Factors and Establishment of Prognostic Scoring System for Secondary Adult Hemophagocytic Syndrome.

Authors:  Qiaolei Zhang; Youyan Lin; Yejiang Bao; Yuan Jin; Xiujin Ye; Yamin Tan
Journal:  Curr Oncol       Date:  2022-02-15       Impact factor: 3.677

6.  Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.

Authors:  Ailin Zhao; Jinrong Yang; Meng Li; Linfeng Li; Xinai Gan; Jie Wang; He Li; Kai Shen; Yunfan Yang; Ting Niu
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 7.  Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.

Authors:  Marcel Levi
Journal:  Hemasphere       Date:  2021-06-01

8.  Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis.

Authors:  Sandrine Valade; Bérangère S Joly; Agnès Veyradier; Jehane Fadlallah; Lara Zafrani; Virginie Lemiale; Amélie Launois; Alain Stepanian; Lionel Galicier; Claire Fieschi; Adrien Mirouse; Jean Jacques Tudesq; Anne-Claire Lepretre; Elie Azoulay; Michael Darmon; Eric Mariotte
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

Review 9.  Coagulopathy of Coronavirus Disease 2019.

Authors:  Toshiaki Iba; Jerrold H Levy; Marcel Levi; Jean Marie Connors; Jecko Thachil
Journal:  Crit Care Med       Date:  2020-09       Impact factor: 9.296

10.  Clinical significance and influencing factors of fibrinogen in ANCA-associated vasculitis: A single-center retrospective study from Southwest China.

Authors:  Naidan Zhang; Jiaxiang Sun; Chaixia Ji; Yusha Zhou; Xiao Bao; Chengliang Yuan
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.